ZVRA
Zevra Therapeutics is a biopharmaceutical company focused on developing therapies for rare diseases, aiming to bring life-changing treatments through data-driven drug development and a patient-centered regulatory narrative. The company highlights its scientific approach, clinical development, and a late-stage pipeline with commercial products and partnered programs. Based in the United States, Zevra emphasizes addressing unmet medical needs and partnering with healthcare professionals to advance therapies for rare disorders.
No recent news for this company.
No recent deals for this company.